Liver study tests how body handles new drug

NCT ID NCT06957756

First seen Feb 21, 2026 · Last updated Apr 28, 2026 · Updated 10 times

Summary

This study looks at how mild, moderate, and severe liver problems change the way the body processes a medicine called BI 1584862. About 44 adults, some with liver issues and some without, will take a single dose of the drug. Researchers will monitor safety and measure drug levels in the blood to understand the impact of liver function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • American Research Corporation

    RECRUITING

    San Antonio, Texas, 78215, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Arizona Clinical Trials - Chandler

    RECRUITING

    Chandler, Arizona, 85225, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Omega Research Orlando, LLC

    RECRUITING

    Orlando, Florida, 32808, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.